Known glioma risk loci are associated with glioma with a family history of brain tumours - A case-control gene association study

International Journal of Cancer

Volumn 132, Issue 10, 2013, Pages 2464-2468

  Melin, Beatrice ^a   Dahlin, Anna M ^a   Andersson, Ulrika ^a   Wang, Zhaoming ^b   Henriksson, Roger ^a   Hallmans, Göran ^a   Bondy, Melissa L ^c   Johansen, Christoffer ^d   Feychting, Maria ^e   Ahlbom, Anders ^e   Kitahara, Cari M ^b   Wang, Sophia S ^f   Ruder, Avima M ^g   Carreõn, Tania ^g   Butler, Mary Ann ^g   Inskip, Peter D ^b   Purdue, Mark ^b   Hsing, Ann W ^b   Mechanic, Leah ^b   Gillanders, Elizabeth ^b   Yeager, Meredith ^b   Linet, Martha ^b   Chanock, Stephen J ^b   Hartge, Patricia ^b   Rajaraman, Preetha ^b   more..

^a UMEÅ UNIVERSITY   (Sweden)

^b NATIONAL CANCER INSTITUTE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^e KAROLINSKA INSTITUTE   (Sweden)

^f CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^g NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

brain tumours; genome wide association study; Glioma; single nucleotide polymorphism

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BRAIN TUMOR; CANCER RISK; CASE CONTROL STUDY; CDKN2A GENE; CDKN2B GENE; CHROMOSOME 20Q; CHROMOSOME 5P; CHROMOSOME 9P; CONTROLLED STUDY; DENMARK; FAMILY HISTORY; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RTEL1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN; TERT GENE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA HELICASES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLIOBLASTOMA; GLIOMA; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; SWEDEN; TELOMERASE; UNITED STATES;

EID: 84874936750     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27922     Document Type: Article

References (21)

1. CBTRUS, CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2004-2008. Central Brain Tumor Registry of the United States, Hinsdale, IL, 2012.
2. Bondy ML, Scheurer ME, Malmer B, et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 2008; 113: 1953-68.
3. Malmer B, Adatto P, Armstrong G, et al. GLIOGENE an International Consortium to Understand Familial Glioma. Cancer Epidemiol Biomarkers Prev 2007; 16: 1730-4.
4. Malmer B, Iselius L, Holmberg E, et al. Genetic epidemiology of glioma. Br J Cancer 2001; 84: 429-34.
5. Melin B,. Genetic causes of glioma: new leads in the labyrinth. Curr Opin Oncol 2011; 23: 643-7.
6. Sanson M, Hosking FJ, Shete S, et al. Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet 2011; 20: 2897-904.
7. Shete S, Hosking FJ, Robertson LB, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 2009; 41: 899-904.
8. Wrensch M, Jenkins RB, Chang JS, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 2009; 41: 905-8.
9. Rajaraman P, Melin BS, Wang Z, et al. Genome-wide association study of glioma and meta-analysis. Hum Genet 2012; 131: 1877-88.
10. Inskip PD, Hatch EE, Stewart PA, et al. Study design for a case-control investigation of cellular telephones and other risk factors for brain tumours in adults. Radiat Prot Dosimetry 1999; 86: 45-52.
11. Hayes RB, Reding D, Kopp W, et al. Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 2000; 21: 349S-55S.
12. Hallmans G, Agren A, Johansson G, et al. Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort-evaluation of risk factors and their interactions. Scand J Public Health Suppl 2003; 61: 18-24.
13. Ruder AM, Waters MA, Carreon T, et al. The Upper Midwest Health Study: a case-control study of primary intracranial gliomas in farm and rural residents. J Agric Saf Health 2006; 12: 255-74.
14. Cardis E, Richardson L, Deltour I, et al. The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur J Epidemiol 2007; 22: 647-64.
15. Egan KM, Thompson RC, Nabors LB, et al. Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J Neurooncol 2011; 104: 535-42.
16. Uringa EJ, Youds JL, Lisaingo K, et al. RTEL1: an essential helicase for telomere maintenance and the regulation of homologous recombination. Nucleic Acids Res 2011; 39: 1647-55.
17. Paunu N, Lahermo P, Onkamo P, et al. A novel low-penetrance locus for familial glioma at 15q23-q26.3. Cancer Res 2002; 62: 3798-802.
18. Malmer B, Haraldsson S, Einarsdottir E, et al. Homozygosity mapping of familial glioma in Northern Sweden. Acta Oncol 2005; 44: 114-9.
19. Shete S, Lau CC, Houlston RS, et al. Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium. Cancer Res 2011; 71: 7568-75.
20. Jenkins RB, Wrensch MR, Johnson D, et al. Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer Genet 2011; 204: 13-8.
21. Simon M, Hosking FJ, Marie Y, et al. Genetic risk profiles identify different molecular etiologies for glioma. Clin Cancer Res 2010; 16: 5252-9.